Dexcom Inc (DXCM) is now in the Undervalued zone, suggesting that its current forward PE ratio of 27.81 is considered Undervalued compared with the five-year average of 87.69. The fair price of Dexcom Inc (DXCM) is between 99.28 to 303.55 according to relative valuation method. Compared to the current price of 73.78 USD , Dexcom Inc By Undervalued By 25.69%.

Relative Value

Fair Zone

99.28-303.55

Current Price：73.78

25.69%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Dexcom Inc (DXCM) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Dexcom Inc (DXCM) has a current Price-to-Book (P/B) ratio of 9.52. Compared to its 3-year average P/B ratio of 16.76, the current P/B ratio is approximately -43.20% higher. Relative to its 5-year average P/B ratio of 18.37, the current P/B ratio is about -48.17% higher. Dexcom Inc (DXCM) has a Forward Free Cash Flow (FCF) yield of approximately 4.09%. Compared to its 3-year average FCF yield of 1.75%, the current FCF yield is approximately 134.06% lower. Relative to its 5-year average FCF yield of 1.20%, the current FCF yield is about 240.33% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for DXCM competitors is 4.64, providing a benchmark for relative valuation. Dexcom Inc Corp (DXCM.O) exhibits a P/S ratio of 5.13, which is 10.58% above the industry average. Given its robust revenue growth of 13.12%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of DXCM increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of DXCM in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is DXCM currently overvalued or undervalued?

What is Dexcom Inc (DXCM) fair value?

DXCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Dexcom Inc (DXCM) is between 99.28 to 303.55 according to relative valuation method.

How does DXCM's valuation metrics compare to the industry average?

The average P/S ratio for DXCM's competitors is 4.64, providing a benchmark for relative valuation. Dexcom Inc Corp (DXCM) exhibits a P/S ratio of 5.13, which is 10.58% above the industry average. Given its robust revenue growth of 13.12%, this premium appears unsustainable.

What is the current P/B ratio for Dexcom Inc (DXCM) as of Mar 03 2026?

As of Mar 03 2026, Dexcom Inc (DXCM) has a P/B ratio of 9.52. This indicates that the market values DXCM at 9.52 times its book value.

What is the current FCF Yield for Dexcom Inc (DXCM) as of Mar 03 2026?

As of Mar 03 2026, Dexcom Inc (DXCM) has a FCF Yield of 4.09%. This means that for every dollar of Dexcom Inc's market capitalization, the company generates 4.09 cents in free cash flow.

What is the current Forward P/E ratio for Dexcom Inc (DXCM) as of Mar 03 2026?

As of Mar 03 2026, Dexcom Inc (DXCM) has a Forward P/E ratio of 27.81. This means the market is willing to pay $27.81 for every dollar of Dexcom Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Dexcom Inc (DXCM) as of Mar 03 2026?

As of Mar 03 2026, Dexcom Inc (DXCM) has a Forward P/S ratio of 5.13. This means the market is valuing DXCM at $5.13 for every dollar of expected revenue over the next 12 months.

DXCM Valuation